Clinical trial
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
NCT04519749 is registered in ClinicalTrials.gov with 4D Molecular Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
- Lead sponsor
- 4D Molecular Therapeutics
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- September 1, 2020
- Completion date
- June 30, 2030
- Enrollment
- 18 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.